{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T17:20:21Z","timestamp":1765041621797,"version":"3.41.2"},"reference-count":38,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T00:00:00Z","timestamp":1749081600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100015831","name":"Radius Health Inc.","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015831","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Abaloparatide treatment significantly increased BMD at the LS, TH, and FN compared with placebo in men with osteoporosis in the phase 3 ATOM trial. The current study used 3D-DXA modeling to evaluate the effects of abaloparatide on cortical and trabecular compartments of the proximal femur in ATOM study participants. Proximal femur DXA images were retrospectively analyzed using 3D-DXA (3D-Shaper software v2.12.0, 3D-Shaper Medical, Barcelona, Spain) to evaluate changes in bone parameters from baseline at months 6 and 12 in all randomized men from the ATOM trial. Between-group comparisons were made for percent change from baseline data based on a mixed-effect repeated-measure model with treatment, visit, treatment-by-visit interaction, and type of DXA scanner as fixed effects. Other covariates include BMI, age, and baseline values of bone parameters. Abaloparatide treatment significantly increased integral volumetric BMD (vBMD) (3.7%), trabecular vBMD (7.0%), cortical thickness (1.1%), and cortical surface BMD (1.7%) at 12\u00a0mo compared to baseline (p\u00a0&amp;lt;\u2009.0001). Changes were greater for abaloparatide compared to placebo for all 4 parameters (p\u00a0&amp;lt;\u2009.01). Significant increases from baseline compared to placebo in integral vBMD (2.7% vs \u22120.1%, p\u00a0&amp;lt;\u2009.0001) and trabecular vBMD (6.1% vs \u22120.6%, p\u00a0&amp;lt;\u2009.0001) were also observed at 6\u00a0mo. In conclusion, in men with osteoporosis, abaloparatide improved proximal femur 3D-DXA parameters broadly consistent with results in postmenopausal women in the ACTIVE study, adding to the growing data on abaloparatide bone structure effects at the hip.<\/jats:p>","DOI":"10.1093\/jbmrpl\/ziaf098","type":"journal-article","created":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T08:17:57Z","timestamp":1749111477000},"source":"Crossref","is-referenced-by-count":1,"title":["The effect of abaloparatide on the proximal femur in men with osteoporosis assessed by three-dimensional dual-energy X-ray absorptiometry"],"prefix":"10.1093","volume":"9","author":[{"given":"Ruban","family":"Dhaliwal","sequence":"first","affiliation":[{"name":"Division of Endocrinology, Department of Internal Medicine, The University of Texas Southwestern Medical Center , Dallas, TX 75390 ,","place":["United States"]},{"name":"Endocrine Unit, Massachusetts General Hospital , Boston, MA 02114 ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Boxberger","sequence":"additional","affiliation":[{"name":"Business and Corporate Development, Radius Health Inc. , Boston, MA 00210 ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yamei","family":"Wang","sequence":"additional","affiliation":[{"name":"Biostatistics , Radius Health Inc., Boston, MA 00210,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce H","family":"Mitlak","sequence":"additional","affiliation":[{"name":"Clinical Development , Radius Health Inc., Boston, MA 00210,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ludovic","family":"Humbert","sequence":"additional","affiliation":[{"name":"President and Scientific Development, 3D-Shaper Medical , Barcelona 08007 ,","place":["Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neil","family":"Binkley","sequence":"additional","affiliation":[{"name":"Osteoporosis Clinical Research Program, University of Wisconsin-Madison , Madison, WI 53705 ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,6,5]]},"reference":[{"issue":"10","key":"2025072107262278500_ref1","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1007\/s00198-021-05900-y","article-title":"The clinician's guide to prevention and treatment of osteoporosis","volume":"33","author":"LeBoff","year":"2022","journal-title":"Osteoporos Int"},{"issue":"1","key":"2025072107262278500_ref2","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.mayocp.2014.09.011","article-title":"Burden of illness for osteoporotic fractures compared with other serious diseases among postmenopausal women in the United States","volume":"90","author":"Singer","year":"2015","journal-title":"Mayo Clin Proc"},{"issue":"2","key":"2025072107262278500_ref3","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.bone.2013.07.011","article-title":"Improvements in hip trabecular, subcortical, and cortical density and mass in postmenopausal women with osteoporosis treated with denosumab","volume":"56","author":"Genant","year":"2013","journal-title":"Bone"},{"issue":"4","key":"2025072107262278500_ref4","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1359\/jbmr.081223","article-title":"Severity of vertebral fractures is associated with alterations of cortical architecture in postmenopausal women","volume":"24","author":"Sornay-Rendu","year":"2009","journal-title":"J Bone Miner Res"},{"issue":"1","key":"2025072107262278500_ref5","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s40001-021-00556-0","article-title":"Management of proximal femur fractures in the elderly: current concepts and treatment options","volume":"26","author":"Fischer","year":"2021","journal-title":"Eur J Med Res"},{"issue":"4","key":"2025072107262278500_ref6","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1007\/BF01774015","article-title":"Stress distributions within the proximal femur during gait and falls: implications for osteoporotic fracture","volume":"5","author":"Lotz","year":"1995","journal-title":"Osteoporos Int"},{"issue":"7","key":"2025072107262278500_ref7","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1093\/oxfordjournals.aje.a008800","article-title":"Heterogeneity of hip fracture: age, race, sex, and geographic patterns of femoral neck and trochanteric fractures among the US elderly","volume":"143","author":"Karagas","year":"1996","journal-title":"Am J Epidem"},{"issue":"3","key":"2025072107262278500_ref8","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1359\/jbmr.090820","article-title":"Quantitative computed tomographic assessment of the effects of 24 months of teriparatide treatment on 3D femoral neck bone distribution, geometry, and bone strength: results from the EUROFORS study","volume":"25","author":"Borggrefe","year":"2010","journal-title":"J Bone Miner Res"},{"issue":"11","key":"2025072107262278500_ref9","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.3390\/diagnostics13111877","article-title":"Site-specific differences in bone mineral density of proximal femur correlate with the type of hip fracture","volume":"13","author":"Li","year":"2023","journal-title":"Diagnostics (Basel)"},{"issue":"4","key":"2025072107262278500_ref10","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1093\/jbmr\/zjae028","article-title":"3D-modeling from hip DXA shows improved bone structure with romosozumab followed by denosumab or alendronate","volume":"39","author":"Lewiecki","year":"2024","journal-title":"J Bone Miner Res"},{"issue":"8","key":"2025072107262278500_ref11","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1002\/jbmr.2817","article-title":"Age- and sex-related changes in bone microarchitecture and estimated strength: a three-year prospective study using HRpQCT","volume":"31","author":"Shanbhogue","year":"2016","journal-title":"J Bone Miner Res"},{"issue":"1","key":"2025072107262278500_ref12","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1148\/radiol.12110462","article-title":"Osteoporosis imaging: state of the art and advanced imaging","volume":"263","author":"Link","year":"2012","journal-title":"Radiology"},{"issue":"10","key":"2025072107262278500_ref13","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.1007\/s00198-018-4624-4","article-title":"Effects of osteoporosis drug treatments on cortical and trabecular bone in the femur using DXA-based 3D modeling","volume":"29","author":"Winzenrieth","year":"2018","journal-title":"Osteoporos Int"},{"issue":"3","key":"2025072107262278500_ref14","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1007\/s00198-020-05806-1","article-title":"Differential effects of abaloparatide and teriparatide on hip cortical volumetric BMD by DXA-based 3D modeling","volume":"32","author":"Winzenrieth","year":"2021","journal-title":"Osteoporos Int"},{"issue":"12","key":"2025072107262278500_ref15","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.1007\/s00198-024-07208-z","article-title":"Real-world efficacy of a teriparatide biosimilar (RGB-10) compared with reference teriparatide on bone mineral density, trabecular bone score, and bone parameters assessed using quantitative ultrasound, 3D-SHAPER((R)) and high-resolution peripheral computer tomography in postmenopausal women with osteoporosis and very high fracture risk","volume":"35","author":"Hadji","year":"2024","journal-title":"Osteoporos Int"},{"issue":"1","key":"2025072107262278500_ref16","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s11657-024-01415-1","article-title":"Effects of differences in dose and frequency of teriparatide on bone structure in proximal femur. -Analysis by DXA-based 3D-modeling (3D-SHAPER software)-TRIPLE-BONE study (The effects of TeRIParatide preparation on bone mineral density increase and BONE structure)","volume":"19","author":"Takada","year":"2024","journal-title":"Arch Osteoporos"},{"issue":"1","key":"2025072107262278500_ref17","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1109\/TMI.2016.2593346","article-title":"3D-DXA: assessing the femoral shape, the trabecular macrostructure and the cortex in 3D from DXA images","volume":"36","author":"Humbert","year":"2017","journal-title":"IEEE Trans Med Imaging"},{"key":"2025072107262278500_ref18","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.bone.2018.10.015","article-title":"Bone mineral density response rates are greater in patients treated with abaloparatide compared with those treated with placebo or teriparatide: results from the ACTIVE phase 3 trial","volume":"120","author":"Miller","year":"2015","journal-title":"Bone"},{"issue":"7","key":"2025072107262278500_ref19","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1001\/jama.2016.11136","article-title":"Effect of abaloparatide vs placebo on new vertebral fractures in postmenopausal women with osteoporosis: a randomized clinical trial","volume":"316","author":"Miller","year":"2016","journal-title":"JAMA"},{"issue":"3","key":"2025072107262278500_ref20","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.jocd.2021.11.007","article-title":"Abaloparatide effects on cortical volumetric BMD and estimated strength indices of hip subregions by 3D-DXA in women with postmenopausal osteoporosis","volume":"25","author":"Winzenrieth","year":"2022","journal-title":"J Clin Densitom"},{"issue":"12","key":"2025072107262278500_ref21","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.1002\/jbmr.4719","article-title":"The efficacy and safety of abaloparatide-SC in men with osteoporosis: a randomized clinical trial","volume":"37","author":"Czerwinski","year":"2022","journal-title":"J Bone Miner Res"},{"issue":"6","key":"2025072107262278500_ref22","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1097\/corr.0000000000002465","article-title":"What was the epidemiology and global burden of disease of hip fractures from 1990 to 2019? Results from and additional analysis of the global burden of disease study 2019","volume":"481","author":"Dong","year":"2023","journal-title":"Clin Orthop Relat Res"},{"issue":"3","key":"2025072107262278500_ref23","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1359\/jbmr.061113","article-title":"Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025","volume":"22","author":"Burge","year":"2007","journal-title":"J Bone Miner Res"},{"issue":"5","key":"2025072107262278500_ref24","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1007\/s00198-024-07016-5","article-title":"Differences in femoral fracture localizations in men and women in Switzerland between 1998 and 2021-reversal of the secular trend?","volume":"35","author":"Lippuner","year":"2024","journal-title":"Osteoporos Int"},{"issue":"6914","key":"2025072107262278500_ref25","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1136\/bmj.307.6914.1248","article-title":"Mortality and morbidity after hip fractures","volume":"307","author":"Keene","year":"1993","journal-title":"BMJ"},{"issue":"1","key":"2025072107262278500_ref26","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/s0149-2918(04)90002-1","article-title":"Osteoporosis in men: epidemiology, diagnosis, prevention, and treatment","volume":"26","author":"Olszynski","year":"2004","journal-title":"Clin Ther"},{"issue":"2","key":"2025072107262278500_ref27","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1002\/jbmr.2033","article-title":"Microstructural failure mechanisms in the human proximal femur for sideways fall loading","volume":"29","author":"Nawathe","year":"2014","journal-title":"J Bone Miner Res"},{"issue":"1","key":"2025072107262278500_ref28","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1007\/s11657-023-01344-5","article-title":"The effects of abaloparatide on hip geometry and biomechanical properties in Japanese osteoporotic patients assessed using DXA-based hip structural analysis: results of the Japanese phase 3 ACTIVE-J trial","volume":"18","author":"Sone","year":"2023","journal-title":"Arch Osteoporos"},{"issue":"3","key":"2025072107262278500_ref29","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1007\/s00198-017-4323-6","article-title":"Abaloparatide, a novel PTH receptor agonist, increased bone mass and strength in ovariectomized cynomolgus monkeys by increasing bone formation without increasing bone resorption","volume":"29","author":"Doyle","year":"2018","journal-title":"Osteoporos Int"},{"issue":"4","key":"2025072107262278500_ref30","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1038\/s41584-024-01094-9","article-title":"Evidence-based guideline for the management of osteoporosis in men","volume":"20","author":"Fuggle","year":"2024","journal-title":"Nat Rev Rheumatol"},{"issue":"11","key":"2025072107262278500_ref31","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1002\/jbmr.124","article-title":"Association between bone turnover rate and bone microarchitecture in men: the STRAMBO study","volume":"25","author":"Chaitou","year":"2010","journal-title":"J Bone Miner Res"},{"issue":"9","key":"2025072107262278500_ref32","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1002\/jbmr.3456","article-title":"Low muscle strength and mass is associated with the accelerated decline of bone microarchitecture at the distal radius in older men: the prospective STRAMBO study","volume":"33","author":"Wagner","year":"2018","journal-title":"J Bone Miner Res"},{"issue":"12","key":"2025072107262278500_ref33","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1359\/jbmr.060904","article-title":"Bone fragility: failure of periosteal apposition to compensate for increased endocortical resorption in postmenopausal women","volume":"21","author":"Szulc","year":"2006","journal-title":"J Bone Miner Res"},{"issue":"9","key":"2025072107262278500_ref34","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1007\/s00198-023-06817-4","article-title":"Update on the clinical use of trabecular bone score (TBS) in the management of osteoporosis: results of an expert group meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO), and the International Osteoporosis Foundation (IOF) under the auspices of WHO collaborating Center for Epidemiology of Musculoskeletal Health and Aging","volume":"34","author":"Shevroja","year":"2023","journal-title":"Osteoporos Int"},{"issue":"6","key":"2025072107262278500_ref35","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1177\/1759720x16670154","article-title":"Bone modeling and remodeling: potential as therapeutic targets for the treatment of osteoporosis","volume":"8","author":"Langdahl","year":"2016","journal-title":"Ther Adv Musculoskelet Dis"},{"issue":"6","key":"2025072107262278500_ref36","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1002\/jbmr.1870","article-title":"Comparative effects of teriparatide and risedronate in glucocorticoid-induced osteoporosis in men: 18-month results of the EuroGIOPs trial","volume":"28","author":"Gl\u00fcer","year":"2013","journal-title":"J Bone Miner Res"},{"issue":"1150","key":"2025072107262278500_ref37","doi-asserted-by":"publisher","first-page":"20221016","DOI":"10.1259\/bjr.20221016","article-title":"High-resolution peripheral quantitative computed tomography: research or clinical practice?","volume":"96","author":"Gazzotti","year":"2026","journal-title":"Br J Radiol"},{"key":"2025072107262278500_ref38","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1038\/bonekey.2016.59","article-title":"Osteoporosis drug effects on cortical and trabecular bone microstructure: a review of HR-pQCT analyses","volume":"5","author":"Lespessailles","year":"2016","journal-title":"Bonekey Rep"}],"container-title":["JBMR Plus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jbmrplus\/advance-article-pdf\/doi\/10.1093\/jbmrpl\/ziaf098\/63439999\/ziaf098.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmrplus\/article-pdf\/9\/8\/ziaf098\/63439999\/ziaf098.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmrplus\/article-pdf\/9\/8\/ziaf098\/63439999\/ziaf098.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T11:26:30Z","timestamp":1753097190000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jbmrplus\/article\/doi\/10.1093\/jbmrpl\/ziaf098\/8157179"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,5]]},"references-count":38,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,7,5]]}},"URL":"https:\/\/doi.org\/10.1093\/jbmrpl\/ziaf098","relation":{},"ISSN":["2473-4039"],"issn-type":[{"type":"electronic","value":"2473-4039"}],"subject":[],"published-other":{"date-parts":[[2025,8]]},"published":{"date-parts":[[2025,6,5]]},"article-number":"ziaf098"}}